Biophytis (Group)

https://www.biophytis.com

BIOPHYTIS is a biotech company founded in 2006 and specialized in aging diseases. It develops innovative therapeutic solutions on pathologies, without treatment, in order to restore the muscular and visual functions. BIOPHYTIS focuses its R&D efforts in the fight against the age-related macular degeneration (AMD) and the age-related muscular dystrophy (Sarcopenia). On these two highly invalidating diseases, the company has proprietary candidates entering in phase 2b. Installed in the Biocitech technopark (Romainville-Paris), BIOPHYTIS has also a subsidiary in Brazil (Sao Paulo). The company is based on leading research collaborations with the UPMC (Pierre et Marie Curie University), the ICAN (Institute of Cardiometabolism and Nutrition), the Institute of Myologie and the Vision Institute. For more information, please visit: www.biophytis.com BIOPHYTIS is eligible for the French PEA-PME regime *

	Start	2006-01-01 established
	Today	Biophytis S.A. (Euronext Growth Paris: ALBPS)
	Industry	BIOTECH
	Industry 2	Sarconeos
	Person	Veillet, Stanislas (Biophytis 200609– CEO + Co-founder)
	Person 2	Schneiderman, Daniel (Biophytis 201907 CFO)

	Region	Romainville
	Country	France
	Street	102 avenue Gaston Roussel Parc Biocitech
	City	93230 Romainville
	Tel	+33-1-4183-6600
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2024-02-12